Lipid Droplet Biology and Perilipins
Formation and Surface
| Stage | Components | What it determines |
|---|---|---|
| Nucleation | Seipin (BSCL2), FIT2, triglyceride synthesis at the ER | Where droplets form and how many |
| Growth | Local triglyceride synthesis; droplet–droplet fusion | Size distribution |
| Surface coating | PLIN2, PLIN3 (constitutive); PLIN1, PLIN5 (tissue-specific) | Access of lipases; turnover competence |
| Interaction | Mitochondria, peroxisomes, autophagosomes | Transfer and clearance routes |
| Turnover | ATGL (PNPLA2), HSL (LIPE), MGL; lipophagy | Mobilisation rate |
Important distinction. Droplet number is set by nucleation; droplet size is set by growth and fusion. Many small droplets and few large droplets can have identical total lipid and different biology — the first indicates ongoing nucleation, the second indicates growth and reduced surface-to-volume ratio, which changes the access of lipases.
Part 1 — The Perilipins
| Protein | Expression | Function | Readout consideration |
|---|---|---|---|
| PLIN1 | Adipocytes, steroidogenic cells | Blocks lipolysis until phosphorylated | Not a general droplet marker |
| PLIN2 | Ubiquitous; induced by fatty acids and PPAR | Coat protein; stabilises droplets | Commonly used as a "droplet marker", but also an ER-stress and PPAR target |
| PLIN3 | Ubiquitous | Early droplet coating; replaces with maturation | Marks nascent droplets |
| PLIN4 | Adipocytes | Structural | Less studied |
| PLIN5 | Oxidative tissues: heart, skeletal muscle, liver | Links droplets to mitochondria; promotes contact | Indicates oxidative demand |
Caveat on PLIN2 as a marker. PLIN2 is regulated by PPARα/δ, by ER stress and by fatty acid availability, so an increase can occur without an increase in droplet number. Using it as a quantitative proxy for lipid storage conflates three variables. Imaging for droplets plus PLIN2 immunostaining is more informative than either alone, because it reports both number and coat composition.
Caveat on PLIN5. PLIN5 promotes droplet–mitochondria contacts and can either promote or restrain lipolysis depending on phosphorylation state. A PLIN5 increase is therefore a statement about contact and oxidative demand, not about storage.
Part 2 — Measuring Droplets
| Measurement | What it reports | Caveat |
|---|---|---|
| Droplet count per cell | Nucleation | Depends on a size threshold; small droplets missed |
| Droplet size distribution | Growth and fusion | Requires per-object analysis, not total area |
| Total neutral lipid area | Content | Cannot distinguish number from size |
| PLIN2 immunofluorescence | Coat protein | Induced independently of droplet number |
| Pulse-chase with labelled fatty acid | Turnover | Requires a defined chase and a label that does not re-enter |
| Lipophagy flux | Autophagic delivery | Requires lysosomal inhibition arms |
Readout note. "Total droplet area per cell" is the most commonly reported and the least informative: a cell with 200 small droplets and a cell with 8 large ones can produce the same number. Per-object analysis — at least a size histogram — costs little and answers the question the total area cannot.
Part 3 — Turnover: Three Routes
| Route | Machinery | Timescale | Measurement |
|---|---|---|---|
| Cytosolic lipolysis | ATGL → HSL → MGL | Minutes | Glycerol or fatty acid release; inhibitor panel |
| Lipophagy | Autophagosome → lysosome | Hours | Flux with and without lysosomal inhibition |
| Droplet–droplet transfer or fusion | — | Variable | Live imaging |
Caveat on lipophagy measurement. Colocalisation between droplets and LC3 or between droplets and lysosomes is not delivery. The flux design — with and without a lysosomal inhibitor, and with a marker of autophagic sequestration — is what establishes the route, exactly as for macroautophagy elsewhere in this series. In cells with large droplets, the lysosome may be unable to engulf an entire droplet, so "macro-lipophagy" and "microlipophagy" may coexist with different kinetics.
Part 4 — Droplets as Protection
The pillar's central claim — that esterification is protective — is expressed at the droplet. Three lines of evidence support it.
- • DGAT1 overexpression increases droplet storage and reduces fatty acid-induced death in several models.
- • Reduced droplet formation (seipin loss, PLIN2 loss in some contexts) can worsen injury while lowering neutral lipid.
- • Droplet–mitochondria contacts provide a route for controlled fatty acid transfer, which appears to buffer rather than amplify oxidative stress in oxidative tissues.
The counter-consideration is that droplet accumulation can also be a marker of failed mobilisation, and in that case the droplet is a consequence rather than a defence. Distinguishing the two requires turnover data: a cell that is storing and mobilising rapidly is in a different state from one that is storing and not mobilising.
Part 5 — Model Requirements and Recurring Failures
| Requirement | Why |
|---|---|
| Fatty acid delivery defined (BSA ratio) | Droplet formation depends on the free fatty acid concentration |
| Timepoint after loading recorded | Droplets grow and coalesce over hours |
| Imaging method stated | Confocal versus widefield changes apparent number |
| Fixation compatibility | Some stains and fixatives dissolve droplets |
| Turnover measured | Content alone cannot distinguish storage from stasis |
| Cell type noted | Adipocytes, hepatocytes and macrophages differ substantially |
Recurring failures:
- • Total droplet area reported as "lipid accumulation", hiding number and size.
- • PLIN2 used as a droplet count.
- • Colocalisation reported as lipophagy.
- • Droplets counted after fixation that extracts neutral lipid.
- • No turnover measurement, so protection and failure are indistinguishable.
- • Adipocyte-derived reagents and protocols applied to hepatocytes without re-validation.
- • Droplet–mitochondria contacts inferred from proximity in fixed cells without a functional readout.
Part 6 — Where This Article Connects
Droplets are the storage module of the lipid pillar, and their surface proteins connect to the oxidation module (PLIN5 and contacts), the esterification module (DGAT), and the autophagic clearance routes described in the stress domain. The droplet staining article in this cluster covers dye choice and quantification; the droplet isolation article covers proteomics and its artefacts.
If you need droplet turnover and contact measured rather than inferred, we can scope the study with you.
Contact EDITGENE to request a project consultation or quote.
Scientific scope and validation note
Droplet number, size and surface composition vary with cell type, fatty acid supply and time after loading. The relationships here are principles, not fixed properties.
Neutral lipid content does not establish droplet number, and droplet abundance does not establish whether storage is protective or a marker of failed mobilisation.
Scientific interpretation and experimental design
- • Number and size are different measurements. Report the distribution.
- • PLIN2 is regulated independently of droplets.
- • Turnover distinguishes protection from stasis.
- • Lipophagy needs flux, not colocalisation.
- • Fixation can dissolve the object you are counting.
- • Contacts need a functional readout.
Selected references for further reading
- • Olzmann JA, Carvalho P. Dynamics and functions of lipid droplets. Nature Reviews Molecular Cell Biology. 2019;20:137–155.
- • Listenberger LL, et al. Triglyceride accumulation protects against fatty acid-induced lipotoxicity. PNAS. 2003;100:3077–3082.
- • Krahmer N, et al. Balancing the size of the lipid droplet and the endoplasmic reticulum. Cell Metabolism. 2011;14:504–515.
- • Najt CP, et al. Lipid droplet-derived monounsaturated fatty acids traffic via PLIN5 to allosterically activate SIRT1. Molecular Cell. 2020;77:810–824.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| PBRM1 Knockout A-549 Cell Line | EDJ0001-K01 | Human | 55193 | Details Get a Quote |
| YTHDC1 Knockout A-549 Cell Line | EDC07652 | Human | 91746 | Details Get a Quote |
| TP53 Knockout HCT 116 Cell Line | EDC07854 | Human | 7157 | Details Get a Quote |
| Sirt2 Knockout MH-S Cell Line | EDJ-KQ78173 | Mouse | 64383 | Details Get a Quote |
| TFE3 Knockout KGN Cell Line | EDJ-KQ48 | Human | 7030 | Details Get a Quote |
| Stub1 Knockout MB49 Cell Line | EDJ-KQ53 | Mouse | 56424 | Details Get a Quote |
| ARID1A Knockout SNK-6 Cell Line | EDJ-KQ64 | Human | 8289 | Details Get a Quote |
| Tet1 Knockout Kupffer Cell Line | EDJ-KQ88 | Mouse | 52463 | Details Get a Quote |
| NR1H3 Knockout HEK293T Cell Line | EDJ-KQ109 | Human | 10062 | Details Get a Quote |
| NR1H2 Knockout HEK293T Cell Line | EDJ-KQ110 | Human | 7376 | Details Get a Quote |
| RPS6KB2 Knockout HEK293 Cell Line | EDJ-KQ125 | Human | 6199 | Details Get a Quote |
| SMAD6 Knockout HEK293 Cell Line | EDJ-KQ126 | Human | 4091 | Details Get a Quote |
| JUN Knockout HEK293 Cell Line | EDJ-KQ176 | Human | 3725 | Details Get a Quote |
| JUN Knockout HEK293T Cell Line | EDJ-KQ184 | Human | 3725 | Details Get a Quote |
| ALKBH5 Knockout HEK293 Cell Line | EDJ-KQ186 | Human | 54890 | Details Get a Quote |
- 1
- 2
- ...
- Next Page »